| Autor: |
Karakus, Savas, Sahin, Ali, Durmaz, Yunus, Aydin, Huseyin, Yildiz, Caglar, Akkar, Ozlem, Dogan, Mansur, Cengiz, Ahmet, Cetin, Meral, Cetin, Ali |
| Předmět: |
|
| Zdroj: |
Journal of Obstetrics & Gynaecology Research; Feb2017, Vol. 43 Issue 2, p303-307, 5p, 1 Chart, 2 Graphs |
| Abstrakt: |
Aim The aim of this study was to determine ovarian reserve status using anti-müllerian hormone (AMH) level and antral follicle count (AFC) in patients with Sjögren's syndrome (SS). Methods Twenty-four women with SS diagnosed according to the classification criteria proposed by the American-European Consensus Group and 25 healthy women as controls were enrolled in this study. Ovarian reserve was assessed on clinical findings, AFC, and serum AMH and reproductive hormone levels. Results Compared with the healthy controls, in the SS patients, the duration of menstrual cycle was significantly shorter ( P = 0.043); serum AMH ( P = 0.001) and AFC ( P = 0.001) were significantly lower, and serum luteinizing hormone (LH) was significantly higher ( P = 0.019). The right ( P = 0.555) and left ovarian ( P = 0.386) volumes were also lower but this did not reach statistical significance. Serum follicle-stimulating hormone ( P = 0.327), estradiol ( P = 0.241), and prolactin ( P = 0.55) were similar between the two groups. Conclusions Ovarian reserve may be reduced in SS patients. For the assessment of ovarian reserve, serum AMH and ovarian AFC with serum LH may be useful. Further studies with long-term follow-up are required to determine the course of ovarian reserve abnormalities and best possible biomarkers of reduced ovarian reserve in SS patients. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text